ACAD
ACADIA Pharmaceuticals Inc. Healthcare - Biotechnology Investor Relations →
ACADIA Pharmaceuticals Inc. (ACAD) closed at $23.56 as of 2026-02-02, trading 16.4% above its 200-week moving average of $20.23. The stock is currently moving closer to the line, down from 24.1% last week. The 14-week RSI sits at 53, indicating neutral momentum.
Over the past 1084 weeks of data, ACAD has crossed below its 200-week moving average 15 times. On average, these episodes lasted 39 weeks. Historically, investors who bought ACAD at the start of these episodes saw an average one-year return of +142.3%.
With a market cap of $4.0 billion, ACAD is a mid-cap stock. The company generates a free cash flow yield of 0.7%. Return on equity stands at 35.0%, indicating strong profitability. The stock trades at 4.3x book value.
Share count has increased 3.5% over three years, indicating dilution. ACAD passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.
Over the past 20.8 years, a hypothetical investment of $100 in ACAD would have grown to $269, compared to $849 for the S&P 500. ACAD has returned 4.9% annualized vs 10.8% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: ACAD vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ACAD Crosses Below the Line?
Across 15 historical episodes, buying ACAD when it crossed below its 200-week moving average produced an average return of +142.8% after 12 months (median +11.0%), compared to +13.4% for the S&P 500 over the same periods. 57% of those episodes were profitable after one year. After 24 months, the average return was +157.1% vs +24.5% for the index.
Each line shows $100 invested at the moment ACAD crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ACAD has crossed below its 200-week MA 15 times with an average 1-year return of +142.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jun 2006 | Oct 2006 | 17 | 39.4% | +70.5% | +165.6% |
| Dec 2006 | Mar 2007 | 12 | 23.8% | +25.6% | +168.0% |
| Feb 2008 | Mar 2012 | 211 | 91.2% | -91.6% | +137.5% |
| Apr 2012 | Jun 2012 | 11 | 17.0% | +714.3% | +1429.9% |
| Jul 2012 | Aug 2012 | 1 | 1.1% | +1251.7% | +1460.3% |
| Jan 2016 | Mar 2016 | 9 | 15.3% | +54.3% | +13.9% |
| Oct 2016 | Nov 2016 | 4 | 19.2% | +49.6% | -0.5% |
| Nov 2016 | Dec 2016 | 3 | 5.5% | +11.1% | -13.2% |
| May 2017 | Jul 2017 | 10 | 12.8% | -36.1% | -18.8% |
| Nov 2017 | Jul 2019 | 90 | 57.7% | -34.1% | -17.6% |
| Sep 2019 | Sep 2019 | 1 | 12.4% | +60.8% | -1.0% |
| Mar 2021 | Jul 2023 | 122 | 54.1% | -14.3% | -12.9% |
| Jul 2023 | Dec 2023 | 20 | 28.6% | -34.1% | -18.9% |
| Jan 2024 | May 2025 | 69 | 41.8% | -35.6% | -13.7% |
| Oct 2025 | Oct 2025 | 1 | 0.6% | N/A | +17.4% |
| Average | 39 | — | +142.3% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02